474 related articles for article (PubMed ID: 15093889)
1. Short QT syndrome: pharmacological treatment.
Gaita F; Giustetto C; Bianchi F; Schimpf R; Haissaguerre M; Calò L; Brugada R; Antzelevitch C; Borggrefe M; Wolpert C
J Am Coll Cardiol; 2004 Apr; 43(8):1494-9. PubMed ID: 15093889
[TBL] [Abstract][Full Text] [Related]
2. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
3. Hydroquinidine therapy in Brugada syndrome.
Hermida JS; Denjoy I; Clerc J; Extramiana F; Jarry G; Milliez P; Guicheney P; Di Fusco S; Rey JL; Cauchemez B; Leenhardt A
J Am Coll Cardiol; 2004 May; 43(10):1853-60. PubMed ID: 15145111
[TBL] [Abstract][Full Text] [Related]
4. Short QT Syndrome: a familial cause of sudden death.
Gaita F; Giustetto C; Bianchi F; Wolpert C; Schimpf R; Riccardi R; Grossi S; Richiardi E; Borggrefe M
Circulation; 2003 Aug; 108(8):965-70. PubMed ID: 12925462
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and treatment of short QT syndrome.
Wolpert C; Schimpf R; Veltmann C; Giustetto C; Gaita F; Borggrefe M
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):611-7. PubMed ID: 16076272
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular genetics of the short QT syndrome.
Schimpf R; Borggrefe M; Wolpert C
Curr Opin Cardiol; 2008 May; 23(3):192-8. PubMed ID: 18382206
[TBL] [Abstract][Full Text] [Related]
7. Quinidine in short QT syndrome: an old drug for a new disease.
Kaufman ES
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):665-6. PubMed ID: 17521305
[No Abstract] [Full Text] [Related]
8. Short QT syndrome: a review.
Patel U; Pavri BB
Cardiol Rev; 2009; 17(6):300-3. PubMed ID: 19829181
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
[TBL] [Abstract][Full Text] [Related]
10. Short QT syndrome. Genotype-phenotype correlations.
Borggrefe M; Wolpert C; Antzelevitch C; Veltmann C; Giustetto C; Gaita F; Schimpf R
J Electrocardiol; 2005 Oct; 38(4 Suppl):75-80. PubMed ID: 16226079
[TBL] [Abstract][Full Text] [Related]
11. Short QT syndrome. Update on a recent entity.
Maury P; Extramiana F; Sbragia P; Giustetto C; Schimpf R; Duparc A; Wolpert C; Denjoy I; Delay M; Borggrefe M; Gaita F
Arch Cardiovasc Dis; 2008; 101(11-12):779-86. PubMed ID: 19059573
[TBL] [Abstract][Full Text] [Related]
12. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
Fuchs T; Groysman R; Meilichov I
Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of quinidine in high-risk patients with Brugada syndrome.
Belhassen B; Glick A; Viskin S
Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
[TBL] [Abstract][Full Text] [Related]
14. [Familial short QT syndrome].
Lupoqlazoff JM; Denjoy I
Rev Prat; 2007 Jan; 57(2):121-5. PubMed ID: 17432514
[TBL] [Abstract][Full Text] [Related]
15. [Short QT Syndromes].
Schulze-Bahr E
Herz; 2006 Apr; 31(2):118-22; quiz 142-3. PubMed ID: 16738834
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced QT-interval prolongation: considerations for clinicians.
Li EC; Esterly JS; Pohl S; Scott SD; McBride BF
Pharmacotherapy; 2010 Jul; 30(7):684-701. PubMed ID: 20575633
[TBL] [Abstract][Full Text] [Related]
18. Short QT syndrome: a predictable story.
Brugada J; Gussak I; Brugada P
Cardiology; 2014; 128(3):231-3. PubMed ID: 24818800
[No Abstract] [Full Text] [Related]
19. Sudden arrhythmia death syndrome: importance of the long QT syndrome.
Meyer JS; Mehdirad A; Salem BI; Kulikowska A; Kulikowski P
Am Fam Physician; 2003 Aug; 68(3):483-8. PubMed ID: 12924831
[TBL] [Abstract][Full Text] [Related]
20. In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
Schimpf R; Veltmann C; Giustetto C; Gaita F; Borggrefe M; Wolpert C
J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1157-60. PubMed ID: 17711440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
